IndyGeneUS Bio

IndyGeneUS AI | Google for Startups ’23

Slogan: Discovering novel gene targets in underrepresented populations through the power of next generation sequencing 🧬

Description: IndyGeneUS AI is creating the world’s largest block-chain encrypted repository of indigenous and diasporic African/Afro-Latin clinical and multi-omics data for disease prevention/detection, drug discovery and development, and clinical disease management. Launched at the Founder Institute South Africa

Founded: 2021

Industries: Biotechnology, Health Care

Headquarter: United States

Last Investment: $50.00K Pre Seed Round investment at 19 December 2022

Last Investment Investors: Merck Global Health Innovation Fund

IndyGeneUS AI is a pioneering biotechnology startup with a focus on harnessing the power of next-generation sequencing for discovering novel gene targets in traditionally underrepresented populations. Founded in 2021 and headquartered in the United States, the company has already attracted attention from significant investors. In December 2022, Merck Global Health Innovation Fund made a $50.00K pre-seed round investment in the company, showcasing confidence in its innovative approach. With a commitment to creating a comprehensive repository of clinical and multi-omics data for disease prevention, drug discovery, and clinical disease management, IndyGeneUS AI exemplifies a forward-thinking approach to healthcare and biotechnology. The company's incorporation of blockchain encryption adds a layer of security and trust to its groundbreaking initiatives. As the industry continues to evolve, IndyGeneUS AI's emphasis on inclusivity and innovation sets a strong foundation for future growth and impact.